Outcome of high grade gliomas–An institutional experience
Objective: In this study we evaluated the prognostic factors, dosimetry and survival outcome of high grade gliomas receiving radiotherapy with concurrent temozolomide and with or without adjuvant temozolomide. Materials and Methods: Eighty patients with high grade gliomas were treated with concurren...
Main Authors: | Nagarjuna Burela, Nidhi Patni |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Acta Medica International |
Subjects: | |
Online Access: | http://www.actamedicainternational.com/article.asp?issn=2349-0578;year=2017;volume=4;issue=1;spage=66;epage=73;aulast=Burela |
Similar Items
-
Novel diagnostic and therapeutic approaches to malignant glioma
by: Swiss Medical Weekly
Published: (2011-05-01) -
Efficacy and safety of innate and adaptive immunotherapy combined with standard of care in high-grade gliomas: a systematic review and meta-analysis
by: Baofeng Guo, et al.
Published: (2023-07-01) -
The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis
by: Huy Gia Vuong, et al.
Published: (2020-09-01) -
Current FDA-Approved Therapies for High-Grade Malignant Gliomas
by: Jacob P. Fisher, et al.
Published: (2021-03-01) -
Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients
by: Valérie Dutoit, et al.
Published: (2020-02-01)